NCT01769664View on ClinicalTrials.gov

A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris

PHASE1CompletedINTERVENTIONAL

Enrollment

650

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

August 31, 2013

Conditions

Acne Vulgaris

Interventions

DRUG

Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel

Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Taro Pharmaceuticals Inc.) applied once a day in the evening for 77 days (11 weeks)

DRUG

Duac® Topical Gel

Duac® (Clindamycin 1%/Benzoyl Peroxide 5%) Topical Gel (Stiefel) applied once a day in the evening for 77 days (11 weeks)

DRUG

Placebo Topical Gel

Placebo (Vehicle) Topical Gel (Taro Pharmaceuticals Inc.) applied once a day in the evening for 77 days (11 weeks)

All Listed Sponsors

lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT01769664 - A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter